A US office tasked with readying the country for influenza pandemics received an unpleasant surprise last week, when creditors filed a lawsuit intended to force one of its new grantees into bankruptcy.
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The lawsuit was filed the day before the Biomedical Advanced Research and Development Authority (BARDA) in Washington DC announced it had awarded a US$35-million contract to Protein Sciences, a biotechnology company in Meriden, Connecticut. The contract is to support the development of vaccines against pandemic flu viruses, such as the H1N1 strain circling the globe. The award could be extended to $147 million over five years, and require 50 million doses of vaccine to be produced.
But the company's success or failure may depend on the outcome of a lawsuit filed on 22 June by vaccine maker Emergent BioSolutions of Rockville, Maryland, and two other creditors that say Protein Sciences has failed to pay back more than $11 million in loans.
Protein Sciences has developed a way to produce flu vaccines in insect cells -a method that some hope will break the industry's reliance on the tried-andtested but slow process of making them in chicken eggs. Its seasonal-flu vaccine is being considered by the Food and Drug Administration; a decision about its approval could come this year, says chief operating officer Manon Cox.
In BARDA, meanwhile, will receive an influx of funds from the $7.7-billion spending on pandemic flu that was signed into law last week. Spending on vaccines is not specified, but the money will be used mainly for the public-health programmes and supplies needed to cope with the H1N1 pandemic, says Robinson, without sacrificing its investments in vaccine technology. The change does, however, bring the centre more in line with other national climate research centres, very few of which have links to defence funding.
In a statement, an MOD spokesperson said that the cuts, which are effective immediately, were made with a view to "prioritizing success in current operations, such as Afghanistan".
This will be the first time that Met Office climate research has gone without MOD cash.
One-sixth of the agency's total budget of £176.5 million comes from commercial services, but the government, and the MOD in particular, remains its main customer and funder.
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